Journey Medical (DERM) Current Assets (2020 - 2026)

Journey Medical has reported Current Assets for 7 years, with the latest figure at $65.0 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 20.34% year-over-year to $65.0 million; the trailing twelve-month figure through Mar 2026 stood at $65.0 million (up 20.34% YoY), and the FY2025 full-year result was $66.9 million, up 38.8% from the prior year.
• Current Assets for Q1 2026 stood at $65.0 million, down from $66.9 million in the prior quarter.
• The five-year high for Current Assets was $90.3 million in Q1 2022, with the low at $44.7 million in Q3 2023.
• Historically, Current Assets has averaged $60.1 million across 5 years, with a median of $56.4 million in 2025.
• Annual changes were most pronounced in 2023 — Current Assets plunged 43.86% — and 2025, when it soared 38.8%.
• Journey Medical's Current Assets stood at $77.7 million in 2022, then declined by 27.32% to $56.5 million in 2023, then slipped by 14.66% to $48.2 million in 2024, then soared by 38.8% to $66.9 million in 2025, then decreased by 2.85% to $65.0 million in 2026.
• The last three Current Assets figures came in at $65.0 million (Q1 2026), $66.9 million (Q4 2025), and $56.4 million (Q3 2025), per Business Quant data.